We are committed to addressing global health needs and improving standards of care by leveraging our expertise and resources.
Developing Medicines That Benefit Patients
Our research and innovation focuses on developing medicines that deliver strong clinical performance, provide more patient benefit and deliver economic value—especially where there is significant need around the world in certain disease areas. This includes immunology, kidney disease, liver disease, neuroscience and oncology.
~$4.2 billion AbbVie’s adjusted spend on research and development in 2016 to discover and test compounds with the potential to treat more than 482 million people
Collaborating with Health Care Professionals to Treat the Most Pressing Medical Conditions
Our collaborations help us improve existing products and deliver innovation in patient care. We work with health care professionals in the research and development process and in medical education. Their expertise helps us develop and enhance products and therapies to treat conditions such as HIV, arthritis, immunological and metabolic disorders, and cancer.
20% of the world’s population suffers from neglected tropical diseases (NTDs), according to the World Health Organization
Solving Neglected Tropical Diseases
We work hard to address neglected diseases that disproportionally impact the world’s poor and marginalized populations. Nearly 250 of our most experience scientists are collaborating with partners. In 2016 these scientists dedicated more than 21,500 pro-bono hours to drug development projects, advisory boards and compound screening to help solve neglected diseases.
In addition, we provide a large library of diverse chemicals to screen against many NTDs. Our Executive Council on Neglected Diseases coordinates efforts across the company to contribute innovative technologies, compounds for screening and our scientific expertise. Learn more about our NTD partners.